IBD | LQD | IBD / LQD | |
Gain YTD | 7.048 | 8.634 | 82% |
Net Assets | 432M | 32B | 1% |
Total Expense Ratio | 0.43 | 0.14 | 307% |
Turnover | 26.00 | 19.00 | 137% |
Yield | 4.19 | 4.35 | 96% |
Fund Existence | 8 years | 23 years | - |
IBD | LQD | |
---|---|---|
RSI ODDS (%) | 6 days ago60% | 2 days ago51% |
Stochastic ODDS (%) | 2 days ago54% | 2 days ago58% |
Momentum ODDS (%) | 2 days ago70% | 2 days ago55% |
MACD ODDS (%) | 2 days ago67% | 2 days ago58% |
TrendWeek ODDS (%) | 2 days ago71% | 2 days ago63% |
TrendMonth ODDS (%) | 2 days ago72% | 2 days ago62% |
Advances ODDS (%) | 17 days ago67% | 5 days ago64% |
Declines ODDS (%) | 11 days ago51% | 10 days ago61% |
BollingerBands ODDS (%) | 2 days ago58% | 2 days ago65% |
Aroon ODDS (%) | N/A | 2 days ago56% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NDVSX | 17.16 | 0.07 | +0.41% |
MFS New Discovery Value R2 | |||
GITAX | 33.26 | 0.05 | +0.15% |
Goldman Sachs Technology Opps A | |||
MIGLX | 18.39 | N/A | N/A |
Morgan Stanley Inst Global Insgt L | |||
VAFIX | 35.37 | -0.03 | -0.08% |
Invesco American Franchise Y | |||
PAGHX | 121.65 | -0.17 | -0.14% |
Permanent Portfolio Aggressive Growth C |